The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Fatalities from immunotherapy (IT) and skin testing (ST)
Open accessAbstract
The Committee on Allergen Standardization of the American Academy of Allergy and Immunology obtained information about 46 fatalities that had occurred during immunotherapy (IT) or skin testing (ST) since 1945. Sufficient information for complete analysis was provided for 30 patients (six for ST and 24 for IT). Of the 30 fatalities, there were 15 male and 15 female fatalities ranging in age from 7 to 70 years (x = 33 years). Known errors of administration accounted for three and possibly an additional three fatalities. Ten fatalities occurred during seasonal exacerbation of the patient's disease, four in patients who had been symptomatic at the time of the injection, two of whom had been receiving beta-adrenergic blockers. Of the 24 fatalities associated with IT, four had experienced previous reactions, 11 manifested a high degree of sensitivity, and four had been injected with newly prepared extracts. Fifteen of the 30 fatalities had received pollen extracts as part of the fatal injection. Of the six fatalities associated with ST, five were due to intradermal testing without prior puncture testing. The signs and symptoms were variable and did not indicate that death was imminent nor predict the cause of death. The time to onset of the reaction was less than 30 minutes in 22/30, more than 30 minutes in 3/30, and not reported in 5/30. The cause of death in 14/16 patients with asthma was respiratory. Epinephrine had been administered to 18, not administered to three, and was either not recorded or unknown in the remaining nine patients. Since seven to 10 million allergen injections are administered yearly, the risk of a fatal reaction is low and may be lessened even further as additional precautions are taken in the selection and treatment of allergic patients and in improved treatment of the anaphylactic reactions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Severe adverse events related to intradermal testing are rare.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [848]
In the citing paper
“Over a 42-year period, from 1945 to 1987, only 5 fatalities were attributed to intradermal testing without prior prick/puncture testing.848”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [848]
Citations
Cites
Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection.
Empey, D. W., Laitinen, L. A., Jacobs, L., Gold, W. M., & Nadel, J. A. (1976) · PubMed · doi:10.1164/arrd.1976.113.2.131 · Cited by 955
A Controlled Trial of Immunotherapy in Insect Hypersensitivity
Hunt, K. J., Valentine, M. D., Sobotka, A. K., Benton, A. W., Amodio, F. J., & Lichtenstein, L. M. (1978) · New England Journal of Medicine · doi:10.1056/nejm197807272990401 · Cited by 710
Physiologic manifestations of human anaphylaxis.
Smith, P. L., Kagey-Sobotka, A., Bleecker, E. R., Traystman, R., Kaplan, A. P., Gralnick, H., Valentine, M. D., Permutt, S., & Lichtenstein, L. M. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109936 · Cited by 380
Lower threshold and greater bronchomotor responsiveness of asthmatic subjects to sulfur dioxide.
Sheppard, D., Wong, W. S., Uehara, C. F., Nadel, J. A., & Boushey, H. A. (1980) · PubMed · doi:10.1164/arrd.1980.122.6.873 · Cited by 252
VAUGHAN, W. T. (1939) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193912000-00016 · Cited by 234
A Controlled Trial of Methylprednisolone in the Emergency Treatment of Acute Asthma
Littenberg, B., & Gluck, E. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601163140304 · Cited by 231
(1953) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1953.tb96181.x · Cited by 206
Diagnostic tests in ragweed hay fever
Norman, P. S., Lichtenstein, L. M., & Ishizaka, K. (1973) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(73)90059-6 · Cited by 206
A controlled trial of methylprednisolone in the emergency treatment of acute asthma
(1987) · Journal of Critical Care · doi:10.1016/0883-9441(87)90030-x · Cited by 196
Turkeltaub, P. C., Rastogi, S. C., Baer, H., Anderson, M. C., & Norman, P. S. (1982) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(82)90023-9 · Cited by 187
Self-citation
Research works printed but not linked: 6
- Baagoe, 1928, Case of allergic death due to intracutaneous injection of 10 cc of white of hen's egg, Ugeskr Laeger, 90, 550
- Turkeltaub, 1985, The use of quantitative skin testing to assign allergy units to allergenic extracts, Ann Allergy, 55, 303
- Belin, 1977, Diagnostic tests in the skin and serum of workers sensitized to B: subtilis enzymes, Clin Allergy, 7, 55, 10.1111/j.1365-2222.1977.tb01425.x · DOI
- Kelly, 1974, Anaphylaxis, JAMA, 227, 1432, 10.1001/jama.1974.03230250055038 · doi:10.1001/jama.1974.03230250055038
- Lockey, 1979, Allergic emergencies, Hosp Med, 6, 64
- Lockey, 1974, Allergic emergencies, Med Clin North Am, 58, 147, 10.1016/S0025-7125(16)32184-8 · doi:10.1016/s0025-7125(16)32184-8
Cited by
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
“They are less safe to perform because systemic reactions can occur albeit rarely (1178, 1179).”
BackgroundSelf-citationAllergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Brożek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.047 · Cited by 1,813
“They are less safe to perform because systemic reactions can occur albeit rarely (1178, 1179).”
BackgroundAllergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R., & Malling, H.-J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,581
Self-citationAllergen immunotherapy: A practice parameter third update
Cox, L., Nelson, H., Lockey, R., Calabria, C., Chacko, T., Finegold, I., Nelson, M., Weber, R., Bernstein, D. I., Blessing-Moore, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.034 · Cited by 1,256
“4 deaths per year), which is similar to 2 previous surveys of AAAAI physician members.(183,184) In a subsequent 3-year AAAAI/ACAAI Immunotherapy Safety Surveillance study, data were provided by 806 practices representing 1922 SCIT prescribers (>50% response”
BackgroundResultSelf-citation
Metadata
- Authors
- Lockey, R. F., Benedict, L. M., Turkeltaub, P. C., & Bukantz, S. C.
- Affiliations
- University of South Florida (US)
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 1987-04
- Volume
- 79
- Issue
- 4
- Pages
- 660-677
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2050552280
- Cited by
- 570
- References
- 46
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 7 · 2022: 10 · 2021: 6 · 2020: 13 · 2019: 10 · 2018: 8 · 2017: 10 · 2016: 17 · 2015: 18 · 2014: 22 · 2013: 21 · 2012: 14
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Allergy and Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- immunotherapy, skin testing, anaphylaxis, pollen extract, intradermal test, epinephrine administration, asthma
- MeSH terms
- Adult, Allergens, Anaphylaxis, Child, Female, Humans, Immunotherapy, Male, Medication Errors, Middle Aged, Risk, Skin Tests, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fatalities from immunotherapy (IT) and skin testing (ST). https://app.cochat.ai/papers/10.1016/s0091-6749(87)80164-1
- The paper
- Lockey, R. F., Benedict, L. M., Turkeltaub, P. C., & Bukantz, S. C. (1987). Fatalities from immunotherapy (IT) and skin testing (ST). Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/s0091-6749(87)80164-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.